TABLE 1.
Cohort |
FSl, %
|
FSep, %
|
FSm, %
|
FSen, %
|
EF, %
|
Author (reference) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Control | Patient | Control | Patient | Control | Patient | Control | Patient | Control | Patient | ||
CRF | NA | NA | NA | NA | 21.4 | 14.6* | NA | NA | 64.2 | 56.0* | Koh et al (43) |
DM | NA | NA | NA | NA | 21.4 | 15.3* | NA | NA | 64.2 | 60.8 (NS) | |
HBP | NA | NA | NA | NA | 21.4 | 16.7* | NA | NA | 64.2 | 64.7 (NS) | |
HBP | 21 | 18* | NA | NA | 21 | 18* | 37 | 42* | 63 | 69* | Aurigemma et al (6) |
HBP | 18 | 12* | 22 | 11* | 30 | 21* | 44 | 30* | NA | 64 | Palmon et al (9) |
AS | 21 | 9* | NA | NA | 21 | 23 (NS) | 36 | 42* | NA | NA | Dumesnil et al (8) |
P<0.05 versus control. AS Aortic stenosis; CRF Chronic renal failure; DM Diabetes mellitus; EF Ejection fraction; HBP High blood pressure; NA Data not available; NS Not statititically significant. FSm and FSl are generally reduced despite relatively preserved FSen and EFs. FSen are greater than FSm and FSep